Turk Kardiyol Dern Ars. 2016; 44(3): 8-12 | DOI: 10.5543/tkda.2016.72626
Ranolazin: mechanism of antianginal effects
Gazi Üniversitesi Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Ankara
Ranolazin is indicated for the control of angina in patients with chronic stable coronary artery disease. Born as a metabolic modulator, ranolazine is now considered to be a late sodium current blocker. This review tries to summarize the mechanism of antianginal effects of ranolazine.
How to cite this article
Murat Özdemir. Ranolazin: mechanism of antianginal effects. Turk Kardiyol Dern Ars. 2016; 44(3): 8-12
Corresponding Author: Murat Özdemir, Türkiye